British Thoracic Society guideline for non-CF bronchiectasis. Physiological and radiological characterisation of patients diagnosed with chronic obstructive pulmonary disease in primary care. Bronchiectasis, exacerbation indices, and inflammation in chronic obstructive pulmonary disease. Factors associated with bronchiectasis in patients with COPD.
|Published (Last):||7 October 2009|
|PDF File Size:||19.80 Mb|
|ePub File Size:||15.13 Mb|
|Price:||Free* [*Free Regsitration Required]|
Arch Bronconeumol. Management of bronchiectasis in adults. Eur Respir J. Mucosal inflammation in idiopathic bronchiectasis: cellular and molecular mechanisms.
Macrophages, neutrophils and interleukin 8 positive cells in the airways of patients with bronchiectasis. Neutrophil apoptosis, proinflammatory mediators and cell counts in bronchiectasis. Sputum elastase in steady-state bronchiectasis. Pathogenesis of bronchiectasis. Clin Chest Med. Whitters D, Stockley R. Immunity and bacterial colonisation in bronchiectasis. Mechanisms of immune dysfunction and bacterial persistence in noncystic fibrosis bronchiectasis.
Mol Immunol. Bronchial inflammation and colonization in patients with clinically stable bronchiectasis. Assessing immune function in adult bronchiectasis. Clin Exp Immunol. Effect of granulocyte-macrophage colony-stimulating factor on neutrophil function in idiopathic bronchiectasis.
Macrophages, neutrophils and tumor necrosis factor alfa expression in bronchiectatic airways in vivo. Respir Med. Up-regulation of circulating adhesion molecules in bronchiectasis. Human neutrophil peptides and phagocytic deficiency in. Redundant toll like receptor signalling in the pulmonary host response to Pseudomonas aeruginosa. Elastase mediated phosphatidylserine receptor cleavage impairs apoptotic cell clearance in cystic fibrosis and bronchiectasis.
J Clin Invest. Overexpression of matrix metalloproteinases-8 and -9 in bronchiectasis airways in vivo. Immune regulation in idiopathic bronchiectasis. Ann N Y Acad Sci. The Th17 pathway in cystic fibrosis lung disease. Adult non-cystic fibrosis bronchiectasis is characterised by airway luminal Th17 pathway activation. PLoS One. Exhaled H2O2 in steady-state bronchiectasis: relationship with cellular composition in induced sputum, spirometry, and extent and severity of disease.
An investigation into causative factors in patients with bronchiectasis. Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis. Am J Med. Asad S, Opal S. Bench-to-bedside review: Quorum sensing and the role of cell to-cell communication during invasive bacterial infection. Crit Care. Cleavage of CXCR1 on neutrophils disables bacterial killing in cystic fibrosis lung disease. Nat Med. Pseudomonas aeruginosa microevolution during cystic fibrosis lung infection establishes clones with.
Previous page Next page. Human neutrophil peptides and phagocytic deficiency in 23 bronchiectatic lungs. Published on Oct 7, Go explore.
Spanish Guidelines on the Evaluation and Diagnosis of Bronchiectasis in Adults
Sci Rep. Eradication of Pseudomonas aeruginosa with inhaled colistin in adults with non-cystic fibrosis bronchiectasis. Chron Respir Dis. Ches t. Ann Am Thorac Soc. Nebulized hypertonic saline in noncystic fibrosis bronchiectasis: a comprehensive review. Ther Adv Respir Dis.
Spanish Guidelines on Treatment of Bronchiectasis in Adults
Arch Bronconeumol. Management of bronchiectasis in adults. Eur Respir J. Mucosal inflammation in idiopathic bronchiectasis: cellular and molecular mechanisms. Macrophages, neutrophils and interleukin 8 positive cells in the airways of patients with bronchiectasis. Neutrophil apoptosis, proinflammatory mediators and cell counts in bronchiectasis. Sputum elastase in steady-state bronchiectasis.
Chronic obstructive pulmonary disease COPD and bronchiectasias are two of the most frequent and underdiagnosed diseases of the airways. The association between these two entities can be established from different points of view. On the one hand, because of their high prevalence, the co-occurrence of COPD and bronchiectasias in the same patient is not unusual. Lastly, some physiopathologic hypotheses that remain to be demonstrated suggest a causal relation between the two diseases in which COPD, especially severe forms, would constitute a risk factor for the formation of bronchiectasias.. ISSN: Las mil caras de la EPOC.